Aetna modified CPB 0327, its infertility coverage policy, effective December 20, 2025. Here's what billing teams need to know before submitting claims.

Aetna, a CVS Health company, updated Clinical Policy Bulletin 0327 governing infertility services across commercial medical plans. This policy touches a massive code set — 501 CPT codes, 89 HCPCS codes, and 523 ICD-10-CM diagnosis codes — covering everything from intrauterine insemination (CPT 58322) and sperm washing (CPT 58323) to laparoscopic myomectomy (CPT 58545–58546), hysteroscopy (CPT 58555–58563), and advanced reproductive technology (ART) procedures. If your practice bills infertility services to Aetna commercial plans, this update affects your charge capture, your prior authorization workflow, and your drug benefit alignment process.


Quick-Reference Table

Field Detail
Payer Aetna, a CVS Health company
Policy Infertility — CPB 0327
Policy Code CPB 0327
Change Type Modified
Effective Date December 20, 2025
Impact Level High
Specialties Affected Reproductive endocrinology, urology, OB/GYN, general surgery, clinical laboratory
Key Action Audit your precertification workflow for ART drugs and procedures before billing against this updated policy

Aetna Infertility Coverage Criteria and Medical Necessity Requirements 2025

The CPB 0327 Aetna infertility coverage policy adopts the ASRM's 2023 definition of infertility. That definition is broader than what many billing teams are used to seeing in payer policy language.

Under this definition, infertility includes the inability to achieve pregnancy based on medical history, age, physical findings, or diagnostic testing. It also includes patients who need donor gametes or embryos. Critically, the definition explicitly states that nothing in it "shall be used to deny or delay treatment to any individual, regardless of relationship status or sexual orientation."

That language matters for your claim submissions. Denials based on relationship status or sexual orientation are inconsistent with this policy. Document that clearly in your appeals workflow.

Medical Necessity Thresholds by Age

Two distinct requirements govern when ART is appropriate. The first applies to patients without a known etiology. For those patients, Aetna uses an age-based threshold to determine when evaluation should begin: 12 months of regular unprotected intercourse for women under 35, and six months for women 35 and older.

The second requirement is ART-specific. For plans that include an ART benefit, the policy requires a documented trial of egg-sperm contact before ART procedures are authorized. For women under 35, that means four cycles of timed intrauterine or intracervical inseminations (CPT 58322 for IUI, CPT 58321 for intracervical) or 12 months of regular intravaginal inseminations. For women 35 and older, it means four cycles of timed inseminations or six months of regular intravaginal inseminations. These are separate but related thresholds — don't conflate them in your precertification documentation.

Document the trial period clearly in the medical record. If you're billing CPT 58322 (intrauterine insemination) or CPT 58323 (sperm washing) as part of that required trial, that documentation supports both current claims and future ART authorization requests.

Prior Authorization Requirements

Precertification is required for a specific list of fertility drugs. Those drugs include:

#Covered Indication
1Cetrotide (cetrorelix acetate)
2Ganirelix acetate
3Follistim AQ (follitropin beta)
+ 4 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Call (866) 782-2779 or fax (860) 754-2515 for precertification. Use the Specialty Pharmacy Precertification SMN forms from Aetna's provider portal.

The prior authorization requirements for ART drugs include an important bypass option. If the infertility procedure itself has already been approved under the member's Aetna medical benefit plan, Specialty Pharmacy Guideline Management review of the associated ART drugs can be bypassed. You'll need the medical authorization number from the procedure approval to use that bypass.

Some plans require Specialty Pharmacy Guideline Management review of all infertility drugs regardless. Check the member's specific plan before assuming the bypass applies. A missed step here is a direct path to reimbursement delays and claim denial.


Aetna Infertility Exclusions and Non-Covered Indications

The CPB 0327 Aetna infertility coverage policy ties all coverage to medical necessity criteria and plan benefit design. Coverage is not universal across all commercial plans.

Plans without an ART benefit do not cover ART procedures under this policy — regardless of medical necessity. Check the member's benefit plan description before scheduling ART services. Billing ART procedures on a plan without that benefit will produce denials regardless of clinical documentation.

Less invasive approaches must be tried before more invasive ones for plans that do include an ART benefit. The policy is explicit: therapeutic options should proceed in order of invasiveness, directed by a licensed specialist. Jumping straight to IVF without documenting the required trial cycles creates medical necessity risk on every claim.


Coverage Indications at a Glance

Indication Status Relevant Codes Notes
Intrauterine insemination (IUI) Covered if criteria met CPT 58322, 58323 Requires documented trial per age threshold
Intracervical insemination Covered if criteria met CPT 58321 Part of required egg-sperm contact trial
Diagnostic hysteroscopy Covered if criteria met CPT 58555 Surgical hysteroscopy variants also covered (58558–58563)
+ 15 more indications

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

This policy is now in effect (since 2025-12-20). Verify your claims match the updated criteria above.

Aetna Infertility Billing Guidelines and Action Items 2025

#Action Item
1

Verify ART benefit status before scheduling. Pull the member's benefit plan document and confirm whether an ART benefit exists. Do this before the patient's first infertility consultation. Billing ART procedures on a non-ART plan produces automatic denials.

2

Confirm the drug-procedure bypass before submitting pharmacy claims. If you've already received procedure authorization, get the medical authorization number and use it to bypass Specialty Pharmacy Guideline Management review for associated ART drugs. Missing this step sends drug claims through a slower review process — and some will deny, creating reimbursement delays that are entirely avoidable.

3

Document the trial period in the medical record now. For every patient who may eventually need ART, start documenting the egg-sperm contact trial from day one. Log dates of IUI cycles (CPT 58322), intracervical inseminations (CPT 58321), and intravaginal inseminations. You'll need this to support ART prior authorization later.

+ 4 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

Sample Version Diff Line-by-line changes
Previous VersionCurrent Version
Coverage is considered experimental and investigational for all indicationsCoverage is considered medically necessary when specific criteria are met
Prior authorization is not requiredPrior authorization is required for initial treatment
Documentation must include clinical historyDocumentation must include clinical history
+ 1 more action items

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

CPT, HCPCS, and ICD-10 Codes for Infertility Services Under CPB 0327

Covered CPT Codes (When Selection Criteria Are Met)

This policy covers 501 CPT codes. Below are the key codes relevant to most infertility billing teams. Reference the full CPB 0327 Aetna policy at the source for the complete list.

Code Type Description
0167U CPT hCG immunoassay with direct optical observation, blood
0353U CPT Chlamydia trachomatis and Neisseria gonorrhoeae nucleic acid detection
49186 CPT Excision/destruction, open, intra-abdominal (peritoneal, mesenteric, retroperitoneal), primary, up to 5.0 cm
+ 77 more codes

Enter your email to unlock all tables — 100% free

Unlocks every table on this page. Free weekly digest included. By subscribing you agree to our Terms and Privacy Policy.

421 additional CPT codes are listed in the full CPB 0327 policy. Access the complete code set at the Aetna CPB 0327 source document.

HCPCS Codes

The policy includes 89 HCPCS codes covering infertility-related drugs and biologicals. The precertification-required drugs — cetrorelix acetate, ganirelix acetate, follitropin beta, follitropin alfa, menotropins, chorionic gonadotropin, and choriogonadotropin alfa — each carry HCPCS codes subject to Specialty Pharmacy Guideline Management review. Access the full HCPCS code list in the CPB 0327 Aetna system entry at PayerPolicy.

Key ICD-10-CM Diagnosis Codes

The policy maps to 523 ICD-10-CM codes. The full diagnosis code list is available in the CPB 0327 source policy. Your coding team should cross-reference these codes when documenting infertility diagnoses to support medical necessity for covered procedures. Diagnosis codes for male factor infertility, ovulatory dysfunction, tubal disease, endometriosis, and uterine structural anomalies are all represented in the mapped set.


Get the Full Picture for CPT 58322

Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.

🔍 Search by any code 🔔 Real-time alerts 📊 Line-by-line diffs ⏰ Deadline tracking
Get Full Access → $99/mo · 14-day money-back guarantee